{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:25:52Z","timestamp":1781702752773,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007192","name":"RIVM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.05.087","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T01:09:19Z","timestamp":1593047359000},"page":"5516-5524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["MenACWY vaccination campaign for adolescents in the Netherlands: Uptake and its determinants"],"prefix":"10.1016","volume":"38","author":[{"given":"Priscila","family":"de Oliveira Bressane Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alies","family":"van Lier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.05.087_b0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/mr.46.2.162-190.1982","article-title":"The meningococcus and mechanisms of pathogenicity","volume":"46","author":"DeVoe","year":"1982","journal-title":"Microbiol Rev."},{"key":"10.1016\/j.vaccine.2020.05.087_b0010","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/JCM.03584-13","article-title":"Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years","volume":"52","author":"Gasparini","year":"2014","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.vaccine.2020.05.087_b0015","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.vaccine.2020.05.087_b0020","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.vaccine.2019.04.020","article-title":"Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.05.087_b0025","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/cid\/civ506","article-title":"Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex","volume":"61","author":"Stoof","year":"2015","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2020.05.087_b0030","first-page":"1","article-title":"The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015\u20132018","volume":"1","author":"Loenenbach","year":"2019","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2020.05.087_b0035","unstructured":"Knol MJ, de Melker HE, Berbers GAM, van Ravenhorst MB, Ruijs WLM, van Vliet JA, et al. Meningococcal disease in the Netherlands. Background information for the Health Council. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2017. RIVM report 2017-0031."},{"key":"10.1016\/j.vaccine.2020.05.087_b0040","unstructured":"T.M. Schurink-van 't Klooster, H.E. de Melker. The National Immunisation Programme in the Netherlands: Surveillance and developments in 2018-2019. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2019. RIVM report 2019-0193."},{"key":"10.1016\/j.vaccine.2020.05.087_b0045","doi-asserted-by":"crossref","unstructured":"M.J. Knol, W.L.M. Ruijs, L. Antonise-Kamp, H.E. de Melker, A. van der Ende. Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018, Euro Surveill. 23, 2018, pii=18-00158.","DOI":"10.2807\/1560-7917.ES.2018.23.16.18-00158"},{"key":"10.1016\/j.vaccine.2020.05.087_b0050","unstructured":"Gezondheidsraad [The Health Council of the Netherlands]. Vaccinatie tegen meningokokken [Vaccination against meningococcal disease]. The Hague: Gezondheidsraad; 2018. Publication Nr. 2018\/28."},{"key":"10.1016\/j.vaccine.2020.05.087_b0055","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2020.05.087_b0060","doi-asserted-by":"crossref","unstructured":"J.C. Jacobson Vann, R.M. Jacobson, T. Coyne-Beasley, J.K. Asafu-Adjei, P.G. Szilagyi. Patient reminder and recall interventions to improve immunization rates. Cochrane Database of Systematic Reviews. 2018;1 Art. No.: CD003941.","DOI":"10.1002\/14651858.CD003941.pub3"},{"key":"10.1016\/j.vaccine.2020.05.087_b0065","doi-asserted-by":"crossref","DOI":"10.1542\/peds.110.5.e58","article-title":"Reducing geographic, racial, and ethnic disparities in childhood immunization rates by using reminder\/recall interventions in urban primary care practices","volume":"110","author":"Szilagyi","year":"2002","journal-title":"Pediatrics."},{"key":"10.1016\/j.vaccine.2020.05.087_b0070","unstructured":"T.M. Schurink-Van't Klooster, H.E. de Melker. The National Immunisation Programme in the Netherlands: Surveillance and developments in 2017-2018. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2018. RIVM report 2018-0124."},{"key":"10.1016\/j.vaccine.2020.05.087_b0075","unstructured":"Stichting Farmaceutische Kengetallen [Foundation for Pharmaceutical Statistics]. Piek in apotheekverstrekkingen van meningokokkenvaccins. [Peak in pharmacy dispensations of meningococcal vaccines]. Pharmaceutisch Weekblad. 2018;153 Nr 51\/52. https:\/\/www.sfk.nl\/publicaties\/PW\/2018\/piek-in-apotheekverstrekkingen-van-meningokokkenvaccins."},{"key":"10.1016\/j.vaccine.2020.05.087_b0080","first-page":"34","article-title":"Meningokokken C campagne:\u2018da\u2019s goed gedaan?\u2019. Evaluatie van een grootschalige vaccinatiecampagne in 2002","volume":"82","author":"Neppelenbroek","year":"2004","journal-title":"Tijdschr Soc Gezondheidszorg."},{"key":"10.1016\/j.vaccine.2020.05.087_b0085","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.vaccine.2009.12.042","article-title":"Determinants for HPV vaccine uptake in the Netherlands: A multilevel study","volume":"28","author":"Rondy","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.05.087_b0090","unstructured":"E.A. van Lier, P.J. Oomen, H. Giesbers, J.A. van Vliet, I.H. Drijfhout, I.F. Zonnenberg-Hoff, et al. Vaccinatiegraad en jaarverslag Rijksvaccinatieprogramma Nederland 2018. [Immunisation coverage and annual report National Immunisation Programme in the Netherlands 2018]. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2019. RIVM report 2019-0015."},{"key":"10.1016\/j.vaccine.2020.05.087_b0095","unstructured":"P. Blokhuis. Kamerbrief: Voortgang Verder met Vaccineren. [Letter to parliament: Progress with vaccination]. Den Hague: Ministerie Volksgezondheid, Welzijn en Sport.; 2020. Nr. 1637275-200839-PG."},{"key":"10.1016\/j.vaccine.2020.05.087_b0100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/eurpub\/ckt042","article-title":"Vaccine uptake determinants in The Netherlands","volume":"24","author":"van Lier","year":"2014","journal-title":"Eur J Public Health."},{"key":"10.1016\/j.vaccine.2020.05.087_b0105","doi-asserted-by":"crossref","unstructured":"W.L.M. Ruijs, J.L. Hautvast, W.J. van Ansem, R.P. Akkermans, K. van't Spijker, M.E. Hulscher, et al. Measuring vaccination coverage in a hard to reach minority, Eur J Public Health. 22, 2012, 359-64.","DOI":"10.1093\/eurpub\/ckr081"},{"key":"10.1016\/j.vaccine.2020.05.087_b0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2458-11-102","article-title":"Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study","volume":"11","author":"Ruijs","year":"2011","journal-title":"BMC Public Health."},{"key":"10.1016\/j.vaccine.2020.05.087_b0115","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1471-2458-12-408","article-title":"How orthodox protestant parents decide on the vaccination of their children: a qualitative study","volume":"12","author":"Ruijs","year":"2012","journal-title":"BMC Public Health."},{"key":"10.1016\/j.vaccine.2020.05.087_b0120","doi-asserted-by":"crossref","first-page":"pii=20153","DOI":"10.2807\/ese.17.17.20153-en","article-title":"Praeventis, the immunisation register of the Netherlands: a tool to evaluate the National Immunisation Programme","volume":"17","author":"van Lier","year":"2012","journal-title":"Euro Surveill."},{"key":"10.1016\/j.vaccine.2020.05.087_b0125","unstructured":"[dataset] Statusscores - Rangorde naar sociale status van postcodegebieden in Nederland [Status scores - Ranking according to social status of postcode areas in the Netherlands]. Sociaal en Cultureel Planbureau [Netherlands Institute for Social Research]; 2017. https:\/\/www.scp.nl\/Onderzoek\/Lopend_onderzoek\/A_Z_alle_lopende_onderzoeken\/Statusscores."},{"key":"10.1016\/j.vaccine.2020.05.087_b0130","unstructured":"[dataset] Gemeentegrootte en stedelijkheid [Municipality size and urbanization]. Centraal Bureau voor de Statistiek [Statistics Netherlands]; 2018. https:\/\/www.cbs.nl\/nl-nl\/onze-diensten\/methoden\/classificaties\/overig\/gemeentegrootte-en-stedelijkheid."},{"key":"10.1016\/j.vaccine.2020.05.087_b0135","unstructured":"[dataset] Databank verkiezingsuitslagen [Database election results]. Kiesraad [Electoral Council]; 2017. https:\/\/www.verkiezingsuitslagen.nl\/verkiezingen\/detail\/TK20170315."},{"key":"10.1016\/j.vaccine.2020.05.087_b0140","author":"Boersem","year":"2019","journal-title":"Kieskompas"},{"key":"10.1016\/j.vaccine.2020.05.087_b0145","first-page":"197","volume":"25","author":"Biau","year":"2016","journal-title":"A random forest guided tour. TEST."},{"key":"10.1016\/j.vaccine.2020.05.087_b0150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Statist Soc B."},{"key":"10.1016\/j.vaccine.2020.05.087_b0155","unstructured":"RStudio Team. RStudio: Integrated Development Environment for R. Boston, MA: RStudio, Inc.; 2016. http:\/\/www.rstudio.com\/."},{"key":"10.1016\/j.vaccine.2020.05.087_b0160","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2019. https:\/\/www.R-project.org\/."},{"key":"10.1016\/j.vaccine.2020.05.087_b0165","first-page":"18","article-title":"Classification and regression by randomForest","volume":"2","author":"Liaw","year":"2002","journal-title":"R News."},{"key":"10.1016\/j.vaccine.2020.05.087_b0170","unstructured":"Public Health England. Vaccine coverage estimates for the school-based meningococcal ACWY adolescent vaccination programme in England, to 31 August 2018: Health Protection Report; 2019. Vol. 13 Nr. 3."},{"key":"10.1016\/j.vaccine.2020.05.087_b0175","first-page":"1716","article-title":"Meningokokkenziekte in Nederland: mediahype, maar geen epidemie","volume":"145","author":"van Furth","year":"2001","journal-title":"Ned Tijdschr Geneeskd."},{"key":"10.1016\/j.vaccine.2020.05.087_b0180","first-page":"219","article-title":"De huidige vaccinatiecampagne tegen Meningokokken C","volume":"13","author":"De Greeff","year":"2002","journal-title":"Infectieziekten Bulletin."},{"key":"10.1016\/j.vaccine.2020.05.087_b0185","unstructured":"E.I. Schippers. Kamerbrief: Maatregelen tegen meningokokkenziekte [Letter to parliament: Measures against meningococcal disease]. The Hague: Ministry of Health, Welfare and Sport; 2017. Nr.1231923-165496-PG."},{"key":"10.1016\/j.vaccine.2020.05.087_b0190","article-title":"Dodelijke bacterie rukt op in Nederland: 18 doden en 78 ernstig zieken. [Deadly bacteria is advancing in the Netherlands: 18 dead and 78 seriously ill]","author":"Nieuwenhuis","year":"2018","journal-title":"Algemeen Dagblad"},{"key":"10.1016\/j.vaccine.2020.05.087_b0195","article-title":"bezorgdheid bij ouders over meningokokken. [Great concern among parents about meningococcal disease]","author":"Grote","year":"2019","journal-title":"Het Parool"},{"key":"10.1016\/j.vaccine.2020.05.087_b0200","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1186\/s12889-015-2572-x","article-title":"Vaccination decision-making of immigrant parents in the Netherlands; a focus group study","volume":"15","author":"Harmsen","year":"2015","journal-title":"BMC Public Health."},{"key":"10.1016\/j.vaccine.2020.05.087_b0205","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.vaccine.2005.01.075","article-title":"Attitudes and risk perception of parents of different ethnic backgrounds regarding meningococcal C vaccination","volume":"23","author":"Timmermans","year":"2005","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.05.087_b0210","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1097\/01.inf.0000166161.12087.94","article-title":"Challenges to vaccinating adolescents: vaccine implementation issues","volume":"24","author":"Humiston","year":"2005","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.vaccine.2020.05.087_b0215","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1016\/j.vaccine.2008.04.055","article-title":"Current issues in adolescent immunization","volume":"26","author":"Brabin","year":"2008","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2020.05.087_b0220","unstructured":"C. Chen, A. Liaw, L. Breiman. Using Random Forest to Learn Imbalanced Data. Berkeley: University of California; 2004. 110.1-12: 24. http:\/\/statistics.berkeley.edu\/sites\/default\/files\/tech-reports\/666.pdf"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:46:49Z","timestamp":1759402009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20307544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":44,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20307544"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MenACWY vaccination campaign for adolescents in the Netherlands: Uptake and its determinants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}